WallStreetZenWallStreetZen

NASDAQ: TLIS
Talis Biomedical Corp Stock Ownership - Who owns Talis Biomedical?

Insider buying vs selling

Have Talis Biomedical Corp insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TLIS insiders and whales buy or sell their stock.

TLIS Shareholders

What type of owners hold Talis Biomedical Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Randal W. Scott5.44%1,722,565$15.85MInsider
Baker Bros Advisors LP1.80%571,659$5.26MInsider
Baker Bros Advisors LP1.60%508,323$4.68MInstitution
Kimberly J. Popovits1.33%422,891$3.89MInsider
Greenlight Capital Inc0.47%149,052$1.37MInstitution
Brian Coe0.32%100,199$921.83kInsider
Matthew L. Posard0.20%62,500$575.00kInsider
Bml Capital Management LLC0.13%42,743$393.24kInstitution
Ramesh Ramakrishnan0.12%38,619$355.29kInsider
Vanguard Group Inc0.10%31,013$285.32kInstitution

1 of 3

TLIS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TLIS2.51%9.23%
AXGN54.13%45.87%Net SellingNet Selling
LUNG86.31%13.69%Net SellingNet Selling
CVRX36.38%63.62%Net BuyingNet Buying
TLSI2.54%74.24%Net Selling

Talis Biomedical Stock Ownership FAQ

Who owns Talis Biomedical?

Talis Biomedical (NASDAQ: TLIS) is owned by 2.51% institutional shareholders, 9.23% Talis Biomedical insiders, and 88.25% retail investors. Randal W. Scott is the largest individual Talis Biomedical shareholder, owning 1.72M shares representing 5.44% of the company. Randal W. Scott's Talis Biomedical shares are currently valued at $15.50M.

If you're new to stock investing, here's how to buy Talis Biomedical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.